Yale School of Medicine

Internal Medicine

Internal Medicine, Yale School of Medicine

Internal Medicine
333 Cedar Street
Room LMP-1072
P.O. Box 208056
New Haven, CT 06520-8056

Madhav V. Dhodapkar, MD

Madhav V. Dhodapkar, MD

Arthur and Isabel Bunker Chair
Professor of Medicine
Chief, Section of Hematology, Department of Internal Medicine
Director of Hematologic Malignancies, Yale Cancer Center

Hematology

Research Activities

We are interested in studying the biology of the human immune system and how it interacts with growing tumors in patients. We are particularly interested in understanding the tumor and host related factors underlying the transformation of preneoplastic monoclonal gammopathy to its malignant counterpart, multiple myeloma (MM). We are also studying the biology of how human dendritic cells regulate immune responses to different types of antigens. Our goal is to learn to harness the properties of the immune system to detect, prevent and treat cancer, with a particular focus on multiple myeloma.

Education

MB, BS. All India Institute of Medical Sciences, New Delhi, India

Fellowship (Hematology / Oncology): Mayo Clinic, Rochester, MN

Selected Publications

  • Chang D, Osman K, Connolly J, Kukreja A, Krasovsky J, Pack M, Hutchinson A, Geller M, Liu N, Annable R, Shay J, Kirchhoff K, Nishi N, Ando Y, Hayashi K, Hassoun H, Steinman R, Dhodapkar MV. Sustained expansion of NKT cells and antigen specific T cells by ?-galactosyl-ceramide loaded mature DCs. J Exp Med. 2005, 201: 1503-1517.
  • Chang D, Liu N, Klimek V, Hassoun H, Mazumder A, Nimer SD, Jagannath S, Dhodapkar MV. Enhancement of ligand dependent activation of human NKT cells by lenalinomide: Therapeutic implications. Blood. 2006, 108:618-621.
  • Kukreja A, Hutchinson A, Dhodapkar KM, Mazumder A, Vesole D, Angitapalli R, Jagannath S, Dhodapkar MV. Enhancement of clonogenicity of human multiple myeloma by dendritic cells. J Exp Med. 2006, 203:1859-1865.
  • Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath, Dhodapkar MV. Bortezomib enhances dendritic cell mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: Therapeutic implications. Blood. 2007, 109: 4839-4845.
  • Spisek R, Kukreja A, Chen L, Matthews P, Mazumder A, Vesole D, Jagannath S, Zebroski HA, Simpson AJG, Ritter G, Durie B, Crowley J, Shaughnessy Jr. JD, Scanlan M, Gure AO, Barlogie B, Dhodapkar MV. Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J Exp Med. 2007, 204: 831-840.
  • Dhodapkar K, Banerjee D, Connolly J, Kukreja A, Matayeva E, Veri MC, Ravetch JV, Steinman RM, Dhodapkar MV. Selective blockade of the inhibitory FCγ receptor (Fc?RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med. 2007, 204: 1359-1369.

Contact

Campus Address
WWW 4

E-mail
madhav.dhodapkar@yale.edu

Office Phone
(203) 785-4144